Results 21 to 30 of about 55,486 (297)

«Interferon Gamma Release Assays» ou IGRA

open access: yesForum Médical Suisse ‒ Swiss Medical Forum, 2021
Bei IGRA handelt es sich um In-vitro-Tests zum Nachweis von spezifischen Effektor-T-Lymphozyten, die nach Sensibilisierung durch Mycobacterium tuberculosis Interferon gamma produzieren.
Minh Khoa Truong   +4 more
openaire   +1 more source

Tuberculosis infection risk, preventive therapy care cascade and incidence of tuberculosis disease in healthcare workers at Maputo Central Hospital

open access: yesBMC Infectious Diseases, 2019
Background Mozambican healthcare workers have high rates of latent and active tuberculosis, but occupational screening for tuberculosis is not routine in this setting.
Susannah K. Graves   +13 more
doaj   +1 more source

Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical, 2019
Background Tuberculosis screening is recommended in multiple sclerosis patients starting certain disease-modifying therapies. Disease-modifying therapies may affect interferon-gamma release assay results.
Laura E Baldassari   +7 more
doaj   +1 more source

The evolution and role of interferon gamma release assays (IGRAs) in moderate and low income settings.

open access: yesSri Lankan Journal of Infectious Diseases, 2014
The interferon gamma release assays have been extensively evaluated in the diagnosis of latent tuberculosis infection as well as in diagnosis of active pulmonary and extra-pulmonary tuberculosis since their introduction just over a decade ago.
C N Ratnatunga
doaj   +1 more source

Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis [PDF]

open access: yes, 2011
Background Continuing rises in tuberculosis notifications in the UK are attributable to cases in foreign-born immigrants. National guidance for immigrant screening is hampered by a lack of data about the prevalence of, and risk factors for, latent ...
Abubakar, Ibrahim   +18 more
core   +1 more source

INF-gamma Release ELISpot Assay

open access: yesBio-Protocol, 2012
IFN-γ (Interferon-gamma) is produced mainly by activated T cells and NK cells. Production of IFN-γ (Interferon-gamma) by helper T cells as well as cytotoxic T cells is a hallmark of the TH1-type phenotype, thus, high-level production of IFN-γ (Interferon-
Huagang Zhang
doaj   +1 more source

Diagnostic Performance of a Novel CXCL10 mRNA Release Assay for Mycobacterium tuberculosis Infection

open access: yesFrontiers in Microbiology, 2022
One-fourth of the world’s population has been infected with Mycobacterium tuberculosis (M.tb). Although interferon-gamma release assays (IGRAs) have been shown to be valid methods for identifying M.tb infection and auxiliary methods for diagnosis of ...
Liping Pan   +17 more
doaj   +1 more source

Diagnostic Utility of Interferon-Gamma Release Assay in Tuberculous Lymphadenitis [PDF]

open access: yesChinese Medical Sciences Journal, 2019
Objective The aim of this study was to evaluate the diagnostic performance of T-SPOT.TB for tuberculous lymphadenitis. Methods Suspected tuberculous lymphadenitis patients between September 2010 and September 2018 who had both peripheral blood T-SPOT.TB test and lymph node biopsy were retrospectively enrolled in this study.
Xin-Chao, Liu   +10 more
openaire   +2 more sources

Determining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing. [PDF]

open access: yes, 2012
BACKGROUND: Children with latent tuberculosis infection (LTBI) represent a huge reservoir for future disease. We wished to determine Mycobacterium tuberculosis (M.tb) infection prevalence among BCG-immunised five-year-old children in Entebbe, Uganda, but
Webb, Emily L   +35 more
core   +1 more source

Hemodialysis acutely altered interferon-gamma release assay test result and immune cell profile

open access: yesJournal of Microbiology, Immunology and Infection, 2022
Patients receiving hemodialysis (HD) are at risk of TB development. IGRA-positive patients showed significant decrease in quantitative IGRA result with alterations in CD3+CD4+CD45RO+, NK cell, and monocyte subsets immediately upon HD procedure.
Denise Utami Putri   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy